Clinical Trials Logo

Clinical Trial Summary

This double blinded, placebo-controlled randomized trial will compare the safety, efficacy and acceptability of two medical abortion regimens up to 63 days since last Menstrual Period (LMP) in Tunisia and Vietnam. The first regimen will include a 200 mg oral dose of mifepristone followed by 800 mcg buccal misoprostol. The second regimen will include two 800 mcg doses of buccal misoprostol three hours apart. All drugs are administered AT home by the participant.


Clinical Trial Description

n/a


Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT01387256
Study type Interventional
Source Gynuity Health Projects
Contact
Status Completed
Phase Phase 4
Start date May 2009
Completion date July 2010

See also
  Status Clinical Trial Phase
Completed NCT02018796 - Mifepristone and Misoprostol for the Termination of Pregnancy up to 70 Days' Gestation in Kazakhstan N/A
Recruiting NCT01475318 - Study on Combined Use of Letrozole, Mifepristone and Misoprostol in Termination of Pregnancy N/A